FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.8  |  FHIR Version n/a  User: [n/a]

4765211000001107: Tracleer 62.5mg tablets (Janssen-Cilag Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1389181000001115 Tracleer 62.5mg tablets (Janssen-Cilag Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1389191000001118 Tracleer 62.5mg tablets (Janssen-Cilag Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
18320701000001118 Tracleer 62.5mg tablets (Actelion Pharmaceuticals UK Ltd) (product) en Fully specified name Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module
18320801000001110 Tracleer 62.5mg tablets (Actelion Pharmaceuticals UK Ltd) en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tracleer 62.5mg tablets (Janssen-Cilag Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Tracleer 62.5mg tablets (Janssen-Cilag Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Tracleer 62.5mg tablets (Janssen-Cilag Ltd) Is a Product containing precisely bosentan 62.5 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Tracleer 62.5mg tablets (Janssen-Cilag Ltd) Is a Bosentan 62.5mg tablets true Inferred relationship Existential restriction modifier
Tracleer 62.5mg tablets (Janssen-Cilag Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Tracleer 62.5mg tablets (Janssen-Cilag Ltd) Is a Bosentan 62.5mg tablets false Inferred relationship Existential restriction modifier
Tracleer 62.5mg tablets (Janssen-Cilag Ltd) Has active ingredient Bosentan false Inferred relationship Existential restriction modifier
Tracleer 62.5mg tablets (Janssen-Cilag Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Tracleer 62.5mg tablets (Janssen-Cilag Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Tracleer 62.5mg tablets (Janssen-Cilag Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Tracleer 62.5mg tablets (Janssen-Cilag Ltd) Is a Tracleer true Inferred relationship Existential restriction modifier
Tracleer 62.5mg tablets (Janssen-Cilag Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Bosentan true Inferred relationship Existential restriction modifier
Tracleer 62.5mg tablets (Janssen-Cilag Ltd) Has specific active ingredient Bosentan monohydrate false Inferred relationship Existential restriction modifier
Tracleer 62.5mg tablets (Janssen-Cilag Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Tracleer 62.5mg tablets (Janssen-Cilag Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Tracleer 62.5mg tablets (Janssen-Cilag Ltd) Has specific active ingredient Bosentan monohydrate true Inferred relationship Existential restriction modifier
Tracleer 62.5mg tablets (Janssen-Cilag Ltd) Has basis of strength substance Bosentan true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Tracleer 62.5mg tablets (Janssen-Cilag Ltd) 56 tablet 4 x 14 tablets Is pack of False Tracleer 62.5mg tablets (Janssen-Cilag Ltd) Inferred relationship Existential restriction modifier
Tracleer 62.5mg tablets (Janssen-Cilag Ltd) 56 tablet 4 x 14 tablets Has AMP True Tracleer 62.5mg tablets (Janssen-Cilag Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start